A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
NCT03345589
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Primary Biliary Cholangitis
Interventions
DRUG:
18-22mg/kg/d Ursodeoxycholic
DRUG:
13-15mg/kg/d Ursodeoxycholic
Sponsor
West China Hospital